US Stock MarketDetailed Quotes

TCRX TScan Therapeutics

Watchlist
  • 8.990
  • +0.980+12.23%
Close May 14 16:00 ET
  • 8.550
  • -0.440-4.89%
Post 16:58 ET
475.24MMarket Cap-6610P/E (TTM)

TScan Therapeutics Key Stats

TScan Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

7.21M

+132.99%
EPS(YoY)

-0.11

+85.90%

Strong Buy

May 13, 2024

TScan Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 4.007M--
--2024/Q2-- / 3.875M--
--2024/Q1566.000K / 4.300M--
--2023/Q47.211M / 3.454M--
--2023/Q33.887M / 4.451M--
--2023/Q23.148M / 4.374M--
--2023/Q16.803M / 4.304M--
--2022/Q43.096M / 4.098M--
--2022/Q33.363M / 3.930M--
--2022/Q24.056M / 3.004M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 4.007M--
--2024/Q2-- / 3.875M--
--2024/Q1566.000K / 4.300M--
--2023/Q47.211M / 3.454M--
--2023/Q33.887M / 4.451M--
--2023/Q23.148M / 4.374M--
--2023/Q16.803M / 4.304M--
--2022/Q43.096M / 4.098M--
--2022/Q33.363M / 3.930M--
--2022/Q24.056M / 3.004M--

Unlock Free Earnings Estimates

TScan Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 13, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg